IOBT vs BIIB: Which Stock is Better?
Side-by-side comparison of Io Biotech Inc and Biogen Inc in 2026
IOBT
Io Biotech Inc
$0.01
BIIB
Biogen Inc
$178.96
Key Metrics Comparison
| Metric | IOBT | BIIB | Winner |
|---|---|---|---|
| Market Cap | $3.45M | $26.26B | BIIB |
| P/E Ratio | N/A | 20.38 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze IOBT
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IOBT or BIIB a better investment?
Comparing IOBT and BIIB: Io Biotech Inc has a market cap of $3.45M while Biogen Inc has $26.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IOBT and BIIB?
IOBT (Io Biotech Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IOBT or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IOBT or BIIB?
IOBT has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: IOBT or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for IOBT.
Which is the larger company: IOBT or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.26B compared to $3.45M for IOBT.
Should I buy IOBT or BIIB in 2026?
Both IOBT and BIIB have investment merit. IOBT trades at $0.01 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IOBT and BIIB stock?
Key differences: Market Cap ($3.45M vs $26.26B), P/E Ratio (N/A vs 20.4x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).